Healthcare provider profile · identity verified

Melissa Ifantides, DO

Family Practice · SANFORD, ME · NPI 1407992175

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	562	163
Levothyroxine Sodium	Levothyroxine Sodium	359	99
Lisinopril	Lisinopril	302	94
Metoprolol Succinate	Metoprolol Succinate	230	71
Pantoprazole Sodium	Pantoprazole Sodium	225	59
Albuterol Sulfate Hfa	Albuterol Sulfate	171	58
Metformin Hcl	Metformin Hcl	168	50
Lorazepam	Lorazepam	158	35
Simvastatin	Simvastatin	152	44
Amlodipine Besylate	Amlodipine Besylate	141	47
Omeprazole	Omeprazole	129	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	121	28
Gabapentin	Gabapentin	121	44
Sertraline Hcl	Sertraline Hcl	120	42
Tramadol Hcl	Tramadol Hcl	120	30
Hydrochlorothiazide	Hydrochlorothiazide	114	40
Trazodone Hcl	Trazodone Hcl	111	34
Duloxetine Hcl	Duloxetine Hcl	105	27
Meloxicam	Meloxicam	102	26
Oxycodone Hcl	Oxycodone Hcl	96	12
Alprazolam	Alprazolam	91	15
Furosemide	Furosemide	91	28
Losartan Potassium	Losartan Potassium	91	30
Clonazepam	Clonazepam	87	17
Rosuvastatin Calcium	Rosuvastatin Calcium	87	29
Metoprolol Tartrate	Metoprolol Tartrate	83	22
Bupropion Xl	Bupropion Hcl	80	26
Eliquis	Apixaban	79	29
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	72	suppressed
Trulicity	Dulaglutide	68	13
Lovastatin	Lovastatin	67	19
Pregabalin	Pregabalin	65	16
Fluticasone Propionate	Fluticasone Propionate	63	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	62	20
Zolpidem Tartrate	Zolpidem Tartrate	62	15
Buspirone Hcl	Buspirone Hcl	61	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	13
Citalopram Hbr	Citalopram Hydrobromide	55	17
Fluoxetine Hcl	Fluoxetine Hcl	55	19
Prednisone	Prednisone	54	37
Azithromycin	Azithromycin	53	40
Metformin Hcl Er	Metformin Hcl	52	18
Atenolol	Atenolol	51	17
Carvedilol	Carvedilol	51	15
Diclofenac Sodium	Diclofenac Sodium	51	11
Ventolin Hfa	Albuterol Sulfate	49	12
Ezetimibe	Ezetimibe	48	16
Montelukast Sodium	Montelukast Sodium	48	17
Alendronate Sodium	Alendronate Sodium	47	16
Amitriptyline Hcl	Amitriptyline Hcl	45	15
Glipizide Er	Glipizide	45	16
Hydroxyzine Hcl	Hydroxyzine Hcl	45	17
Meclizine Hcl	Meclizine Hcl	45	21
Ibuprofen	Ibuprofen	44	15
Glipizide	Glipizide	43	17
Nystatin	Nystatin	43	18
Oxycontin	Oxycodone Hcl	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	14
Ozempic	Semaglutide	37	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	25
Synthroid	Levothyroxine Sodium	35	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	32	suppressed
Allopurinol	Allopurinol	31	11
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	11
Tamsulosin Hcl	Tamsulosin Hcl	30	11
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Bumetanide	Bumetanide	28	suppressed
Famotidine	Famotidine	28	suppressed
Potassium Chloride	Potassium Chloride	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Triamcinolone Acetonide	Triamcinolone Acetonide	27	16
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Celecoxib	Celecoxib	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Topiramate	Topiramate	21	suppressed
Cephalexin	Cephalexin	20	18
Temazepam	Temazepam	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	12
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Fluconazole	Fluconazole	16	11
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Nexium	Esomeprazole Magnesium	14	suppressed
Tretinoin	Tretinoin	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Finasteride	Finasteride	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Alprazolam Er	Alprazolam	12	suppressed
Estradiol	Estradiol	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error